documents: FDA-2026-N-2476-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-N-2476-0001 | FDA | FDA-2026-N-2476 | Advancing the Use of Digital Health Technologies in Clinical Investigations for Drugs and Biological Products; Request for Information and Comments | Notice | Request for Comments | 2026-03-31 | 2026 | 3 | 2026-03-31 | 2026-06-02 | 2026-04-10 09:00:28 | 2026-06184 | 1 | 0 | 09000064b92439d6 |